ACRO BIOMEDICAL CO., LTD. Quarterly Cost of Revenue in USD from Q4 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Acro Biomedical Co., Ltd. quarterly/annual Cost of Revenue history and growth rate from Q4 2017 to Q2 2023.
  • Acro Biomedical Co., Ltd. Cost of Revenue for the quarter ending June 30, 2023 was $0.000.
  • Acro Biomedical Co., Ltd. Cost of Revenue for the twelve months ending June 30, 2023 was $296K, a 55.8% decline year-over-year.
  • Acro Biomedical Co., Ltd. annual Cost of Revenue for 2022 was $518K, a 44.8% decline from 2021.
  • Acro Biomedical Co., Ltd. annual Cost of Revenue for 2021 was $938K, a 77.5% increase from 2020.
  • Acro Biomedical Co., Ltd. annual Cost of Revenue for 2020 was $529K, a 191% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $296K $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $296K $0 -$222K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-02
Q4 2022 $518K $296K -$152K -33.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-07-21
Q3 2022 $670K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $670K $0 -$420K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.09M $222K +$152K +217% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-02
Q4 2021 $938K $448K +$448K Oct 1, 2021 Dec 31, 2021 10-K 2023-07-21
Q3 2021 $490K $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 $490K $420K +$420K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $70K $70K -$459K -86.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $529K $0 -$181K -100% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 $710K $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 $529K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 $181K -$1.04M -85.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-02
Q4 2018 $7.1M $1.22M -$81.9K -6.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-04-02
Q3 2018 $7.18M $2.15M Jul 1, 2018 Sep 30, 2018 10-KT 2020-03-27
Q2 2018 $1.96M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.77M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $1.3M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.